The effect of caffeic acid phenethyl ester CAPE against cholestatic liver injury in rats

Basit Öğe Kaydı
dc.authorid109416en_US
dc.contributor.authorÇoban, Sacid Abdussemet
dc.contributor.authorYıldız, Fahrettin
dc.contributor.authorTerzi, Alparslan
dc.contributor.authorAl, Behçet
dc.contributor.authorÖzgör, Dinçer
dc.contributor.authorAra, Cengiz
dc.contributor.authorPolat, Alaadin
dc.contributor.authorEşrefoğlu, Mukaddes
dc.date.accessioned2017-08-24T12:02:33Z
dc.date.available2017-08-24T12:02:33Z
dc.date.issued2010
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjectives. Caffeic acid phenethyl ester (CAPE) has been subjected to considerable investigations that have revealed its antioxidant and anti-inflammatory activities in different conditions. But there is not a previous investigation about its effect on cholestatic liver injury. The aim of this study was to investigate the effect of CAPE in rat liver against cholestatic liver injury induced by bile duct ligation. Methods. Swiss-albino rats were recruited in the study as follows; Group 1 rats subjected to simple laparotomy known as the sham group; Group 2 rats subjected to bile duct ligation (BDL); Group 3 bile duct ligated rats treated with CAPE. The third group received CAPE (10 mmol/kg) intraperitoneally daily throughout 14 d. Results. Data showed a decrease in g glutamyl transferase (GGT), aspartate aminotransferase (AST), and alanine aminotransferase levels (ALT) of the CAPE treated rats, compared with BDL group (P < 0.001, P < 0.01, and P < 0.02, respectively). In the CAPE treated rats, tissue levels of malondialdehyde (MDA) and myeloperoxidase (MPO) were significantly lower than that of the BDL group (P < 0.001). The levels of glutathione (GSH) in CAPE treated rats were significantly higher than that of BDL group (P < 0.001). In CAPE treated group, the levels of interleukin- 1alpha (IL-1a) and interleukin-6 (IL-6) were signifi- cantly lower than that of BDL group (P < 0.03, P < 0.02, respectively). Administration of CAPE in the rats with biliary obstruction resulted in inhibition of necro-inflammation.Conclusion. These results suggest that treatment of CAPE maintains antioxidant defenses, reduces oxidative liver injury, cytokine damage, and necroinflammation in bile duct ligated rats. Thus, CAPE seems to be a promising agent for the attenuation of cholestatic liver injury.en_US
dc.identifier.citationÇoban, S. A. Yıldız, F. Terzi, A. Al, B. Özgör, D. Ara, C. Polat, A. Eşrefoğlu, M. (2010). The effect of caffeic acid phenethyl ester CAPE against cholestatic liver injury in rats. J Surg Res. 159, 674–679.en_US
dc.identifier.doi10.1016/j.jss.2008.10.023en_US
dc.identifier.endpage679en_US
dc.identifier.startpage674en_US
dc.identifier.urihttps://hdl.handle.net/11616/7726
dc.identifier.volume159en_US
dc.language.isoenen_US
dc.publisherJ Surg Resen_US
dc.relation.ispartofJ Surg Resen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCaffeic acid phenethyl ester (CAPE)en_US
dc.subjectBile duct ligationen_US
dc.subjectCholestatic liver injuryen_US
dc.titleThe effect of caffeic acid phenethyl ester CAPE against cholestatic liver injury in ratsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Makale Dosyası.pdf
Boyut:
1.12 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Tıp Fakültesi, Genel Cerrahi Anabilim Dalı Koleksiyonu